English

NattoPharma: 2nd Quarter and first half 2016 earnings release

Report this content

Please find attached the 2nd quarter and first half 2016 Earnings Release.

Highlights for the 2nd quarter and for the first half 2016;

2nd Quarter 2016

  • Revenue rose by 73 % to NOK 13,3 million
  • Gross Margin for the period was 50,2 %
  • Adj. EBITDA coming in at NOK -0,35 million
  • Loss before tax was NOK -3,5 million

First half 2016

  • Revenue rose by 78 % to NOK 25,8 million
  • Gross Margin for the period was 50,3 %
  • Adj. EBITDA coming in at NOK -2,4 million
  • Loss before tax was NOK -9,8 million

A presentation will be held via webcast by CEO Daniel H. Rosenbaum and CFO Kjetil Ramsøy at 10 am CET, Wednesday 17th August, followed by a Q&A session directly thereafter.

Please follow the below link to join the webcast;

http://webtv.hegnar.no/presentation.php?webcastId=36175567  




For more information, please contact:

Kjetil Ramsøy

CFO, NattoPharma

E-mail: kjetil.ramsoy@nattopharma.com




This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Tags:

Vitamin K2 NattoPharma MenaQ7 2016 Quarterly Report

Documents & Links